Drugs that Stabilize Microtubules

Taxol binds to hydrophobic taxane pockets at the N-terminal of β-tubulin subunits, causing a conformational change that increases lateral affinity between protofilaments. This prevents detachment of taxol-bound tubulin subunits, stabilizing microtubules and blocking their disassembly. The binding essentially locks the microtubule structure in place.

When taxol binds to spindle apparatus microtubules, it prevents their dynamic instability and promotes polymerization. Spindle fibers lose their ability to segregate chromosomes to opposite poles, halting mitosis and triggering apoptosis in tumor cells. This mechanism makes these drugs effective anticancer agents.

Major microtubule-stabilizing drug classes include taxanes, epothilones, laulimalide, and dictyostatin. Paclitaxel, the first approved microtubule stabilizer in 1993, belongs to the taxane class and is widely used to treat breast, lung, prostate, and ovarian cancers. Taxanes remain the most commonly used class in clinical practice.

Low concentrations cause mitotic slippage during G1 phase, forming multipolar spindle apparatus and triggering cell cycle arrest. Higher dosages cause direct mitotic arrest during G2/M phase, preventing chromosome segregation and producing tetraploid G1 cells that undergo apoptosis. Dosage therefore determines the specific cellular outcome.

Taxane sites are hydrophobic pockets located between lateral interfaces of adjacent protofilaments within the microtubule lumen. These specific binding sites allow stabilizing drugs to bind tubulin dimers and prevent microtubule disassembly, with epothilones also utilizing these same taxane sites for binding. This specificity enables targeted drug action.

ABC transporters overexpressed in tumor cells pump microtubule-stabilizing drugs out of the cell, reducing their intracellular concentration and therapeutic effectiveness. This transporter-mediated resistance is a major limitation in treating certain cancers with these stabilizing agents. Understanding this mechanism helps researchers develop strategies to overcome resistance.

Stabilizing drugs like taxol promote polymerization and prevent depolymerization, freezing spindle fibers in place to halt cell division. Drugs that destabilize microtubules work through opposite mechanisms to disrupt microtubule assembly and function. Understanding both classes helps explain how different chemotherapy agents target rapidly dividing cancer cells.